全文获取类型
收费全文 | 4856篇 |
免费 | 409篇 |
国内免费 | 152篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 134篇 |
妇产科学 | 90篇 |
基础医学 | 631篇 |
口腔科学 | 86篇 |
临床医学 | 592篇 |
内科学 | 960篇 |
皮肤病学 | 96篇 |
神经病学 | 389篇 |
特种医学 | 449篇 |
外科学 | 524篇 |
综合类 | 81篇 |
一般理论 | 13篇 |
预防医学 | 444篇 |
眼科学 | 83篇 |
药学 | 448篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 356篇 |
出版年
2021年 | 55篇 |
2020年 | 51篇 |
2019年 | 54篇 |
2018年 | 78篇 |
2017年 | 62篇 |
2016年 | 67篇 |
2015年 | 68篇 |
2014年 | 113篇 |
2013年 | 148篇 |
2012年 | 167篇 |
2011年 | 187篇 |
2010年 | 116篇 |
2009年 | 128篇 |
2008年 | 158篇 |
2007年 | 276篇 |
2006年 | 170篇 |
2005年 | 191篇 |
2004年 | 174篇 |
2003年 | 133篇 |
2002年 | 143篇 |
2001年 | 166篇 |
2000年 | 119篇 |
1999年 | 143篇 |
1998年 | 121篇 |
1997年 | 111篇 |
1996年 | 114篇 |
1995年 | 101篇 |
1994年 | 62篇 |
1993年 | 77篇 |
1992年 | 122篇 |
1991年 | 99篇 |
1990年 | 99篇 |
1989年 | 142篇 |
1988年 | 112篇 |
1987年 | 111篇 |
1986年 | 87篇 |
1985年 | 91篇 |
1984年 | 83篇 |
1983年 | 72篇 |
1982年 | 63篇 |
1981年 | 68篇 |
1980年 | 61篇 |
1979年 | 71篇 |
1978年 | 66篇 |
1977年 | 65篇 |
1976年 | 56篇 |
1975年 | 38篇 |
1974年 | 38篇 |
1973年 | 34篇 |
1972年 | 33篇 |
排序方式: 共有5417条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation 总被引:7,自引:0,他引:7
We recently found that estrogen deficiency leads to a lowering of thiol antioxidant defenses in rodent bone. Moreover, administration of agents that increase the concentration in bone of glutathione, the main intracellular antioxidant, prevented estrogen-deficiency bone loss, whereas depletion of glutathione by buthionine sulfoximine administration provoked substantial bone loss. To analyze further the mechanism by which antioxidant defenses modulate bone loss, we have now compared expression of the known antioxidant enzymes in osteoclasts. We found that glutathione peroxidase 1 (Gpx), the enzyme primarily responsible for the intracellular degradation of hydrogen peroxide, is overwhelmingly the predominant antioxidant enzyme expressed by osteoclasts and that its expression was increased in bone marrow macrophages by receptor activator of nuclear factor-kappaB ligand (RANKL) and in osteoclasts by 17beta-estradiol. We therefore tested the effect of overexpression of Gpx in osteoclasts by stable transfection of RAW 264.7 (RAW) cells, which are capable of osteoclastic differentiation in response to RANKL, with a Gpx-expression construct. Osteoclast formation was abolished. The Gpx expression construct also suppressed RANKL-induced nuclear factor-kappaB activation and increased resistance to oxidation of dihydrodichlorofluorescein by exogenous hydrogen peroxide. We therefore tested the role of hydrogen peroxide in the loss of bone caused by estrogen deficiency by administering pegylated catalase to mice. We found that catalase prevented ovariectomy-induced bone loss. These results suggest that hydrogen peroxide is the reactive oxygen species responsible for signaling the bone loss of estrogen deficiency. 相似文献
105.
Familial protein S deficiency with a variant protein S molecule in plasma and platelets 总被引:3,自引:0,他引:3
A protein S deficient family presenting a variant protein S molecule in plasma and platelets is described. The propositus, age 20, and two brothers suffered from venous thrombotic disease. The propositus, the only family member studied while taking oral anticoagulants, had a protein S antigen (ag) level of 17% and undetectable activity. As demonstrated by immunoblotting both the propositus and one clinically affected brother (42% ag, 7% activity) presented variant protein S molecules of 65,000 molecular weight (mol wt) while the other clinically affected brother (64% ag, 11% activity) had only protein S with normal electrophoretic mobility of 70,000 mol wt. The mother had normal protein S levels (93% ag, 100% activity) but had both normal and variant protein S molecules and based on her functional protein S data a normal anticoagulant activity of the variant molecule is suggested. One asymptomatic but protein S deficient sister (68% ag, 9% activity) as well as the asymptomatic protein S deficient father (59% ag, 10% activity) had only protein S molecules of 70,000 mol wt. The variant protein S bound to C4b-binding protein in plasma, and differed from normal protein S in carbohydrate content. Platelets of each family member contained the same immunoblotting pattern of normal and variant protein S forms as found in plasma, consistent with the hypothesis that protein S gene expression involves codominant expression of two alleles that is similar in cells that control the synthesis of both platelet and plasma forms of protein S. 相似文献
106.
de Haas M; Kerst JM; van der Schoot CE; Calafat J; Hack CE; Nuijens JH; Roos D; van Oers RH; von dem Borne AE 《Blood》1994,84(11):3885-3894
In four healthy volunteers, we analyzed in detail the immediate in vivo effects on circulating neutrophils of subcutaneous administration of 300 micrograms of granulocyte colony-stimulating factor (G-CSF). Neutrophil activation was assessed by measurement of degranulation. Mobilization of secretory vesicles was shown by a decrease in leukocyte alkaline phosphatase content of the circulating neutrophils. Furthermore, shortly postinjection, Fc gamma RIII was found to be upregulated from an intracellular pool that we identified by immunoelectron microscopy as secretory vesicles. Intravascular release of specific granules was shown by increased plasma levels of lactoferrin and by upregulation of the expression of CD66b and CD11b on circulating neutrophils. Moreover, measurement of fourfold elevated plasma levels of elastase, bound to its physiologic inhibitor alpha 1- antitrypsin, indicated mobilization of azurophil granules. However, no expression of CD63, a marker of azurophil granules, was observed on circulating neutrophils. G-CSF--induced mobilization of secretory vesicles and specific granules could be mimicked in whole blood cultures in vitro, in contrast to release of azurophil granules. Therefore, we postulate that the most activated neutrophils leave the circulation, as observed shortly postinjection, and undergo subsequent stimulation in the endothelial microenvironment, resulting in mobilization of azurophil granules. Our data demonstrate that G-CSF should be regarded as a potent immediate activator of neutrophils in vivo. 相似文献
107.
Adriana Olar Khalida M. Wani Erik P. Sulman Alireza Mansouri Gelareh Zadeh Charmaine D. Wilson Franco DeMonte Gregory N. Fuller Kenneth D. Aldape 《Brain pathology (Zurich, Switzerland)》2015,25(3):266-275
While World Health Organization (WHO) grading of meningioma stratifies patients according to recurrence risk overall, there is substantial within‐grade heterogeneity with respect to recurrence‐free survival (RFS). Most meningiomas are graded according to mitotic counts per unit area on hematoxylin and eosin sections, a method potentially confounded by tumor cellularity, as well as potential limitations of accurate mitotic figure detection on routine histology. To refine mitotic figure assessment, we evaluated 363 meningiomas with phospho‐histone H3 (Ser10) and determined the mitotic index (number of mitoses per 1000 tumor cells). The median mitotic indices among WHO grade I (n = 268), grade II (n = 84) and grade III (n = 11) tumors were 1, 4 and 12. Classification and regression tree analysis to categorize cut‐offs identified three subgroups defined by mitotic indices of 0–2, 3–4 and ≥5, which on univariate analysis were associated with RFS (P < 0.01). In multivariate analysis, mitotic index subgrouped in this manner was significantly associated with RFS (P < 0.01) after adjustment for Simpson grade, WHO grade and MIB‐1 index. Mitotic index was then examined within individual WHO grade, showing that for grade I and grade II meningiomas, mitotic index can add additional information to RFS risk. The results suggest that the use of a robust mitotic marker in meningioma could refine risk stratification. 相似文献
108.
Emma M. Smith Danelle Fuller Hina Mahmood 《Disability and rehabilitation. Assistive technology》2018,13(6):523-526
Purpose: To determine if older adult, novice wheelchair users who drive a power wheelchair with a JoyBar control complete maneuverability tasks in less time and with less error than those who drive a power wheelchair with a standard joystick control.Materials and methods: A parallel randomized controlled trial design conducted at a medical rehabilitation and research centre with ambulatory older adults aged 60 and above (n?=?27). The intervention was the JoyBar alternative wheelchair control. The primary outcome measure was total time to complete each of the two maneuverability tasks. The secondary outcome measure was total number of errors during each of the maneuverability tasks.Results: An independent, two sampled t-test was conducted and revealed that the JoyBar group took a greater amount of time to complete both maneuverability tasks than the control group (p?.05). No significant differences (p?.05) were found in rates of error on either task between the JoyBar and joystick groups.Conclusions: Maneuverability of a powered wheelchair by novice wheelchair users was not improved through the use of the JoyBar when compared to a standard wheelchair joystick, as measured by rates of error and time to complete maneuverability tasks.
- Implications for rehabilitation
Clients who are new to powered wheelchair use may perform maneuverability tasks faster, with equivalent accuracy, using a standard joystick versus the JoyBar.
Clients who use a JoyBar may require adjustments to the programming of their wheelchair to ensure optimal performance.
Additional training may be required to achieve proficiency in maneuverability tasks with a JoyBar versus a standard joystick.
109.
Transfusion of leukoreduced blood products and risk of antibody‐mediated rejection of renal allografts
下载免费PDF全文
![点击此处可从《Transfusion》网站下载免费的PDF全文](/ch/ext_images/free.gif)
110.
Vestal Mark L. Hodulik Kimberly Mando-Vandrick Jennifer James Michael L. Ortel Thomas L. Fuller Matthew Notini Maria Friedland Mark Welsby Ian J. 《Journal of thrombosis and thrombolysis》2022,53(1):167-175
Journal of Thrombosis and Thrombolysis - Limited data exists regarding the clinical outcomes of andexanet alfa and four factor prothrombin complex concentrate (4F-PCC) for reversal of apixaban or... 相似文献